<code id='01258C4286'></code><style id='01258C4286'></style>
    • <acronym id='01258C4286'></acronym>
      <center id='01258C4286'><center id='01258C4286'><tfoot id='01258C4286'></tfoot></center><abbr id='01258C4286'><dir id='01258C4286'><tfoot id='01258C4286'></tfoot><noframes id='01258C4286'>

    • <optgroup id='01258C4286'><strike id='01258C4286'><sup id='01258C4286'></sup></strike><code id='01258C4286'></code></optgroup>
        1. <b id='01258C4286'><label id='01258C4286'><select id='01258C4286'><dt id='01258C4286'><span id='01258C4286'></span></dt></select></label></b><u id='01258C4286'></u>
          <i id='01258C4286'><strike id='01258C4286'><tt id='01258C4286'><pre id='01258C4286'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:6
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          How to fix cancer clinical trials' diversity problem
          How to fix cancer clinical trials' diversity problem

          Clockwisefromtopleft:STAT'sNicholasSt.Fleur(moderator);JudySewards,headofclinicaltrialexperienceatPf

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Covid hospitalizations on the rise, Humana says

          MoreolderadultshavebeenhospitalizedforCovid-19overthepastseveralweeks,accordingtodatareviewedbyhealt